Design of a multiple drug delivery system directed at periodontitis

Sharath C. Sundararaj, Mark V. Thomas, Rebecca Peyyala, Thomas D. Dziubla, David A. Puleo

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Abstract

Periodontal disease is highly prevalent, with 90% of the world population affected by either periodontitis or its preceding condition, gingivitis. These conditions are caused by bacterial biofilms on teeth, which stimulate a chronic inflammatory response that leads to loss of alveolar bone and, ultimately, the tooth. Current treatment methods for periodontitis address specific parts of the disease, with no individual treatment serving as a complete therapy. The present research sought to demonstrate development of a multiple drug delivery system for stepwise treatment of different stages of periodontal disease. More specifically, multilayered films were fabricated from an association polymer comprising cellulose acetate phthalate and Pluronic F-127 to achieve sequential release of drugs. The four types of drugs used were metronidazole, ketoprofen, doxycycline, and simvastatin to eliminate infection, inhibit inflammation, prevent tissue destruction, and aid bone regeneration, respectively. Different erosion times and adjustable sequential release profiles were achieved by modifying the number of layers or by inclusion of a slower-eroding polymer layer. Analysis of antibiotic and anti-inflammatory bioactivity showed that drugs released from the devices retained 100% bioactivity. The multilayered CAPP delivery system offers a versatile approach for releasing different drugs based on the pathogenesis of periodontitis and other conditions.

Original languageEnglish
Pages (from-to)8835-8842
Number of pages8
JournalBiomaterials
Volume34
Issue number34
DOIs
StatePublished - Nov 2013

Bibliographical note

Funding Information:
This research was supported by NIH ( DE019645 and AR060964 ) and Kentucky NASA EPSCoR ( NNX08BA13A ).

Funding

This research was supported by NIH ( DE019645 and AR060964 ) and Kentucky NASA EPSCoR ( NNX08BA13A ).

FundersFunder number
Kentucky NASA EPSCoRNNX08BA13A
National Institutes of Health (NIH)DE019645
National Institute of Arthritis and Musculoskeletal and Skin DiseasesR01AR060964

    Keywords

    • Controlled drug release
    • Drug delivery
    • Drug release
    • Periodontium
    • Sequential drug release

    ASJC Scopus subject areas

    • Mechanics of Materials
    • Ceramics and Composites
    • Bioengineering
    • Biophysics
    • Biomaterials

    Fingerprint

    Dive into the research topics of 'Design of a multiple drug delivery system directed at periodontitis'. Together they form a unique fingerprint.

    Cite this